These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 20059340)

  • 1. Hepatocellular carcinoma: novel molecular approaches for diagnosis, prognosis, and therapy.
    Villanueva A; Minguez B; Forner A; Reig M; Llovet JM
    Annu Rev Med; 2010; 61():317-28. PubMed ID: 20059340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic and prognostic molecular markers in hepatocellular carcinoma.
    Mínguez B; Lachenmayer A
    Dis Markers; 2011; 31(3):181-90. PubMed ID: 22045404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review article: the management of hepatocellular carcinoma.
    Cabrera R; Nelson DR
    Aliment Pharmacol Ther; 2010 Feb; 31(4):461-76. PubMed ID: 19925500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted therapies: Role of sorafenib in HCC patients with compromised liver function.
    Di Maio M; Daniele B; Perrone F
    Nat Rev Clin Oncol; 2009 Sep; 6(9):505-6. PubMed ID: 19707242
    [No Abstract]   [Full Text] [Related]  

  • 5. Sorafenib and radiation therapy for the treatment of advanced hepatocellular carcinoma.
    Horgan AM; Dawson LA; Swaminath A; Knox JJ
    J Gastrointest Cancer; 2012 Jun; 43(2):344-8. PubMed ID: 20683678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sorafenib, doesn't it have any competitor in advanced hepatocellular carcinoma?
    Kim DY; Han KH
    J Gastroenterol Hepatol; 2011 Nov; 26(11):1585-6. PubMed ID: 22011294
    [No Abstract]   [Full Text] [Related]  

  • 7. Downstaging of hepatocellular carcinoma prior to liver transplant: is there a role for adjuvant sorafenib in locoregional therapy?
    Vagefi PA; Hirose R
    J Gastrointest Cancer; 2010 Dec; 41(4):217-20. PubMed ID: 20443078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonoperative therapies for combined modality treatment of hepatocellular cancer: expert consensus conference.
    Burak KW; Thomas MB; Zhu AX
    HPB (Oxford); 2010 Jun; 12(5):321-2. PubMed ID: 20590906
    [No Abstract]   [Full Text] [Related]  

  • 9. Potential impact of sorafenib on the survival benefit of liver transplantation for hepatocellular carcinoma.
    Vitale A; Lombardi G; Ramirez Morales R; Cillo U
    Dig Liver Dis; 2012 May; 44(5):361-2. PubMed ID: 22424640
    [No Abstract]   [Full Text] [Related]  

  • 10. [Diagnosis and treatment of hepatocellular carcinoma].
    Forner A; Ayuso C; Isabel Real M; Sastre J; Robles R; Sangro B; Varela M; de la Mata M; Buti M; Martí-Bonmatí L; Bru C; Tabernero J; Llovet JM; Bruix J
    Med Clin (Barc); 2009 Feb; 132(7):272-87. PubMed ID: 19248879
    [No Abstract]   [Full Text] [Related]  

  • 11. [Sorafenib and radiotherapy association for hepatocellular carcinoma].
    Girard N; Mornex F
    Cancer Radiother; 2011 Feb; 15(1):77-80. PubMed ID: 21239203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety of transarterial chemoembolization plus sorafenib combination treatment in unresectable hepatocellular carcinoma.
    Sinakos E; Dedes I; Papalavrentios L; Drevelegas A; Akriviadis E
    Scand J Gastroenterol; 2010 Apr; 45(4):511-2. PubMed ID: 20113152
    [No Abstract]   [Full Text] [Related]  

  • 13. Maintenance of Sorafenib following combined therapy of three-dimensional conformal radiation therapy/intensity-modulated radiation therapy and transcatheter arterial chemoembolization in patients with locally advanced hepatocellular carcinoma: a phase I/II study.
    Zhao JD; Liu J; Ren ZG; Gu K; Zhou ZH; Li WT; Chen Z; Xu ZY; Liu LM; Jiang GL
    Radiat Oncol; 2010 Feb; 5():12. PubMed ID: 20149262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical analysis of the treatment:transcatheter arterial chemoembolization combined with sorafenib in advanced hepatocellular carcinoma].
    Li Y; Huang JW; Lu LG; Shao PJ; Hu BS; Huang GM; Wei ZG; Zhang L
    Zhonghua Yi Xue Za Zhi; 2010 Aug; 90(31):2187-92. PubMed ID: 21029658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective internal radiation therapy of hepatocellular carcinoma: potential hepatopulmonary shunt reduction after sorafenib administration.
    Theysohn JM; Schlaak JF; Müller S; Ertle J; Schlosser TW; Bockisch A; Lauenstein TC
    J Vasc Interv Radiol; 2012 Jul; 23(7):949-52. PubMed ID: 22720895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective, randomized, double-blind, multi-center, Phase III clinical study on transarterial chemoembolization (TACE) combined with Sorafenib versus TACE plus placebo in patients with hepatocellular cancer before liver transplantation - HeiLivCa [ISRCTN24081794].
    Hoffmann K; Glimm H; Radeleff B; Richter G; Heining C; Schenkel I; Zahlten-Hinguranage A; Schirrmacher P; Schmidt J; Büchler MW; Jaeger D; von Kalle C; Schemmer P
    BMC Cancer; 2008 Nov; 8():349. PubMed ID: 19036146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medical therapies for hepatocellular carcinoma: a critical view of the evidence.
    Villanueva A; Hernandez-Gea V; Llovet JM
    Nat Rev Gastroenterol Hepatol; 2013 Jan; 10(1):34-42. PubMed ID: 23147664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early MRI response monitoring of patients with advanced hepatocellular carcinoma under treatment with the multikinase inhibitor sorafenib.
    Horger M; Lauer UM; Schraml C; Berg CP; Koppenhöfer U; Claussen CD; Gregor M; Bitzer M
    BMC Cancer; 2009 Jun; 9():208. PubMed ID: 19558720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What is the indication for sorafenib in hepatocellular carcinoma? A clinical challenge.
    Kim R; Byrne MT; Tan A; Aucejo F
    Oncology (Williston Park); 2011 Mar; 25(3):283-91, 295. PubMed ID: 21548473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and rationale of the HCC BRIDGE study in China: a longitudinal, multicenter cohort trial in hepatocellular carcinoma.
    Chen M; Therneau T; Orsini LS; Qiao YL
    BMC Gastroenterol; 2011 May; 11():53. PubMed ID: 21569429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.